These results indicate that epigenetic modifications may be involved in the regulation of IRF7 in SARS-CoV-2 infection and AD and the detection of the methylation statuses of some factors in the blood, such as IRF7, which could provide insights for diagnosis and prognosis. Here, IRF7 is linked to Alzheimer disease.